Loading insider details...
Beta
Latest Form 4 (Oct 14, 2026): Sale of 3,221 QTTB shares, $26.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 14, 2026 | Q32 Bio Inc. (QTTB) | Sale | 3,221 | $26.8K |
| Aug 27, 2026 | Q32 Bio Inc. (QTTB) | Sale | 9,845 | $163.0K |
| Jul 21, 2026 | Q32 Bio Inc. (QTTB) | Grant/Award | 132,000 | n/a |
| Mar 20, 2026 | Q32 Bio Inc. (QTTB) | Grant/Award | 132,000 | n/a |
| Feb 28, 2026 | Q32 Bio Inc. (QTTB) | Sale | 9,896 | $44.7K |
| Dec 5, 2025 | Q32 Bio Inc. (QTTB) | Sale | 22,506 | $77.9K |
| Aug 28, 2025 | Q32 Bio Inc. (QTTB) | Sale | 10,494 | $18.9K |
| Feb 27, 2025 | Q32 Bio Inc. (QTTB) | Grant/Award | 132,000 | n/a |
| Jun 28, 2024 | Verve Therapeutics, Inc. (VERV) | Grant/Award | 267,541 | n/a |
| Mar 27, 2024 | Q32 Bio Inc. (QTTB) | Grant/Award | 394,445 | n/a |